Titelia

Holdings of Velan Capital Investment Management LP

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
43 in 3 countries
Top ten
78.0 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Praxis Precision Medicines Inc 100,78132.5M $
2Protara Therapeutics Inc 2,834,65214.8M $
3Sutro Biopharma Inc 512,16012.8M $
4Evommune Inc 446,25510.3M $
5MapLight Therapeutics Inc 492,89310M $
6Tenax Therapeutics Inc 583,3339.3M $
7Abivax SA 77,0008.6M $
8Heron Therapeutics Inc 8,753,2907M $
9Immix Biopharma Inc 740,0006.7M $
10Esperion Therapeutics Inc 1,720,0004.7M $
11Anteris Technologies Global Corp 700,0003.9M $
12InspireMD, Inc. 2,099,6523.4M $
13Xencor Inc 250,0003M $
14AVALO THERAPEUTICS INC 185,1222.8M $
15CytomX Therapeutics Inc 540,0002.5M $
16Verrica Pharmaceuticals Inc 471,5592.5M $
17JASPER THERAPEUTICS INC 2,668,3952.3M $
18Rezolute Inc 750,0002.3M $
19Lyell Immunopharma Inc 102,0002M $
20Viridian Therapeutics Inc 91,1231.8M $
21Rocket Pharmaceuticals Inc 294,6431.1M $
22KAZIA THERAPEUTICS LTD 135,3151M $
23Arrowhead Pharmaceuticals Inc 6,500407.6K $
24Protagonist Therapeutics Inc 3,700390K $
25Ovid therapeutics Inc 160,000355.2K $
26Mineralys Therapeutics Inc 11,000298K $
27Context Therapeutics Inc 100,000262K $
28Nurix Therapeutics Inc 16,000248K $
29Corbus Pharmaceuticals Holdings Inc 26,000244.1K $
30Syndax Pharmaceuticals Inc 10,000233.6K $
31Precision BioSciences Inc 40,000220K $
32Immunome Inc 10,000218.7K $
33Design Therapeutics Inc 20,000212.8K $
34Artiva Biotherapeutics Inc 25,000161K $
35Neumora Therapeutics Inc 80,000156K $
36Replimune Group Inc 20,000153K $
37Larimar Therapeutics Inc 33,000148.5K $
38Xilio Therapeutics Inc 14,285120.1K $
39KALARIS THERAPEUTICS INC 18,000103.9K $
40PMV Pharmaceuticals Inc 73,00090.5K $
41MacroGenics Inc 30,00086.7K $
42Karyopharm Therapeutics Inc 15,00083.6K $
43Gossamer Bio Inc 70,00023K $

Download this table: CSV, JSON

Sector breakdown

  • Unattributed 100.0 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 93.6 %
  • France 5.7 %
  • Australia 0.7 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States41139.9M $93.59 %
2France18.6M $5.74 %
3Australia11M $0.67 %
Cite this page

Titelia. "Holdings of Velan Capital Investment Management LP". https://titelia.com/en/funds/US13F1848809